These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

930 related items for PubMed ID: 23348805

  • 1. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.
    Colclough K, Bellanne-Chantelot C, Saint-Martin C, Flanagan SE, Ellard S.
    Hum Mutat; 2013 May; 34(5):669-85. PubMed ID: 23348805
    [Abstract] [Full Text] [Related]

  • 2. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.
    Ellard S, Colclough K.
    Hum Mutat; 2006 Sep; 27(9):854-69. PubMed ID: 16917892
    [Abstract] [Full Text] [Related]

  • 3. Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4A mutations.
    Kapoor RR, Locke J, Colclough K, Wales J, Conn JJ, Hattersley AT, Ellard S, Hussain K.
    Diabetes; 2008 Jun; 57(6):1659-63. PubMed ID: 18268044
    [Abstract] [Full Text] [Related]

  • 4. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.
    Kyithar MP, Bacon S, Pannu KK, Rizvi SR, Colclough K, Ellard S, Byrne MM.
    Diabetes Metab; 2011 Dec; 37(6):512-9. PubMed ID: 21683639
    [Abstract] [Full Text] [Related]

  • 5. Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene.
    Pearson ER, Boj SF, Steele AM, Barrett T, Stals K, Shield JP, Ellard S, Ferrer J, Hattersley AT.
    PLoS Med; 2007 Apr; 4(4):e118. PubMed ID: 17407387
    [Abstract] [Full Text] [Related]

  • 6. Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A.
    Stanescu DE, Hughes N, Kaplan B, Stanley CA, De León DD.
    J Clin Endocrinol Metab; 2012 Oct; 97(10):E2026-30. PubMed ID: 22802087
    [Abstract] [Full Text] [Related]

  • 7. Hepatocyte nuclear factor 1 alpha (HNF-1 alpha) mutations in maturity-onset diabetes of the young.
    Ellard S.
    Hum Mutat; 2000 Nov; 16(5):377-85. PubMed ID: 11058894
    [Abstract] [Full Text] [Related]

  • 8. Maturity Onset Diabetes of the Young (MODY) in Tunisia: Low frequencies of GCK and HNF1A mutations.
    Ben Khelifa S, Martinez R, Dandana A, Khochtali I, Ferchichi S, Castaño L.
    Gene; 2018 Apr 20; 651():44-48. PubMed ID: 29408271
    [Abstract] [Full Text] [Related]

  • 9. Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY 1 (HNF4A-MODY) and MODY 3 (HNF1A-MODY)?
    Karlsson E, Shaat N, Groop L.
    Diabet Med; 2008 Jul 20; 25(7):788-91. PubMed ID: 18513302
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hepatocyte nuclear factor (HNF)1A and HNF4A substitution occurring simultaneously in a family with maturity-onset diabetes of the young.
    Beijers HJ, Losekoot M, Odink RJ, Bravenboer B.
    Diabet Med; 2009 Nov 20; 26(11):1172-4. PubMed ID: 19929997
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. GCK and HNF1A mutations in Canadian families with maturity onset diabetes of the young (MODY).
    Cao H, Shorey S, Robinson J, Metzger DL, Stewart L, Cummings E, Hegele RA.
    Hum Mutat; 2002 Dec 20; 20(6):478-9. PubMed ID: 12442280
    [Abstract] [Full Text] [Related]

  • 19. Identification of novel GCK and HNF1A/TCF1 mutations and polymorphisms in German families with maturity-onset diabetes of the young (MODY).
    Toaima D, Näke A, Wendenburg J, Praedicow K, Rohayem J, Engel K, Galler A, Gahr M, Lee-Kirsch MA.
    Hum Mutat; 2005 May 20; 25(5):503-4. PubMed ID: 15841481
    [Abstract] [Full Text] [Related]

  • 20. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.
    Besser RE, Shepherd MH, McDonald TJ, Shields BM, Knight BA, Ellard S, Hattersley AT.
    Diabetes Care; 2011 Feb 20; 34(2):286-91. PubMed ID: 21270186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.